Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Eslicarbazepine Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 622Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Sumitomo Pharma Canada, Inc.

    02 4Sunovion Pharmaceuticals Canada Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Sunovion Pharmaceuticals Can...

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sunovion Pharmaceuticals Canada Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2180301

    Filing Date : 1996-07-02

    Strength per Unit : 200 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Sunovion Pharmaceuticals Can...

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sunovion Pharmaceuticals Canada Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2180301

    Filing Date : 1996-07-02

    Strength per Unit : 400 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Sunovion Pharmaceuticals Can...

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sunovion Pharmaceuticals Canada Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2180301

    Filing Date : 1996-07-02

    Strength per Unit : 600 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Sunovion Pharmaceuticals Can...

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sunovion Pharmaceuticals Canada Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2180301

    Filing Date : 1996-07-02

    Strength per Unit : 800 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2016-07-02

    Date Granted : 2004-02-10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Sumitomo Pharma Canada, Inc.

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sumitomo Pharma Canada, Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2607427

    Filing Date : 2005-05-06

    Strength per Unit : 200 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Sumitomo Pharma Canada, Inc.

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sumitomo Pharma Canada, Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2607427

    Filing Date : 2005-05-06

    Strength per Unit : 400 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Sumitomo Pharma Canada, Inc.

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sumitomo Pharma Canada, Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2607427

    Filing Date : 2005-05-06

    Strength per Unit : 600 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sumitomo Pharma Canada, Inc.

    Eslicarbazepine Acetate
    arrow
    2024 ACI Convention
    Not Confirmed

    Sumitomo Pharma Canada, Inc.

    Country
    arrow
    2024 ACI Convention
    Not Confirmed

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    Eslicarbazepine Acetate

    Brand Name : APTIOM

    Patent Number : 2607427

    Filing Date : 2005-05-06

    Strength per Unit : 800 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2025-05-06

    Date Granted : 2015-11-24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF